Semaglutide Injection Shortage

• • Ozempic 0.25 mg or 0.5 mg doses subcutaneous solution for injection, Novo Nordisk, 2 mg/1.5 mL, pen injector, NDC 00169-4132-12 - discontinued
  • Ozempic 1 mg doses subcutaneous solution for injection, Novo Nordisk, 4 mg/3 mL, pen injector, NDC 00169-4130-13
  • Ozempic 2 mg doses subcutaneous solution for injection, Novo Nordisk, 8 mg/3 mL, pen injector, NDC 00169-4772-12
  • Wegovy 0.25 mg dose subcutaneous solution for injection, Novo Nordisk, 0.25 mg/0.5 mL, pen injector, 4 count, NDC 00169-4525-14
  • Wegovy 0.5 mg dose subcutaneous solution for injection, Novo Nordisk, 0.5 mg/0.5 mL, pen injector, 4 count, NDC 00169-4505-14
  • Wegovy 1 mg dose subcutaneous solution for injection, Novo Nordisk, 1 mg/0.5 mL, pen injector, 4 count, NDC 00169-4501-14

• • Novo Nordisk has Ozempic on shortage due to increased demand. Novo Nordisk has discontinued Ozempic 0.25 mg and 0.5 mg dose strength in the 2 mg/1.5 mL presentation. The 0.25 mg and 0.5 mg dose strength in the 2 mg/3 mL presentation is available.
  • Novo Nordisk has Wegovy on shortage due to increased demand. The company has taken measures to increase production capacity, however the supply is not anticipated to meet patient demand for the 0.25 mg, 0.5 mg, and 1 mg dose strengths. Additional product supply information can be found at https://www.novonordisk-us.com/products/product-supply-update.html

• • Ozempic 0.25 mg or 0.5 mg doses subcutaneous solution for injection, Novo Nordisk, 2 mg/3 mL, pen injector, NDC 00169-4181-13
  • Wegovy 1.7 mg dose subcutaneous solution for injection, Novo Nordisk, 1.7 mg/0.75 mL, pen injector, 4 count, NDC 00169-4517-14
  • Wegovy 2.4 mg dose subcutaneous solution for injection, Novo Nordisk, 2.4 mg/0.75 mL, pen injector, 4 count, NDC 00169-4524-14

Estimated Resupply Dates

• • Novo Nordisk has Wegovy 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, and 1 mg/ 0.5 mL prefilled pens on allocation. The 1.7 mg/0.75 mL and 2.4 mg/0.75 mL prefilled pens are available; however, there may be periodic shipping delays due to high demand.
  • Novo Nordisk has Ozempic 1 mg and 2 mg presentations on allocation.